diabetes

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

The burden of care after breast cancer treatment is on oncologists, other specialists & primary care providers. Here's a new Duke-edited guide for treating survivors.

An estimated 10.5% of new diagnoses of colorectal cancer will be in men and women younger than 50. Now there's new screening guidelines.

Enrolling a large number of Black men, Duke researchers found potential new paths for improved studies and treatments.

In the age of Covid, Community Outreach & Engagement at DCI comes of age, team expands with disparities researcher/associate director

Angelo Moore, PhD, MSN, RN, NE-BC, retired from the Army in 2015, but his service to his countrymen continues. In civilian life, he serves the historically underserved.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

Donald P. McDonnell, PhD, and Christopher B. Newgard, PhD, have both received 2020 Laureate Awards from the Endocrine Society.

Duke researchers are exploring how nutrients and chemicals in food navigate the same molecular pathways used by certain cancer therapies to slow tumor growth.